Event chart DICE THERAPEUTICS, INC. |
|
|
Upcoming events on DICE THERAPEUTICS, INC. |
|
05/11/23 | | Q1 2023 Earnings Release (Projected) |
08/10/23 | | Interim 2023 Earnings Release (Projected) |
11/09/23 | | Q3 2023 Earnings Release (Projected) |
03/18/24 | | FY 2023 Earnings Release (Projected) |
|
Past events on DICE THERAPEUTICS, INC. |
|
03/18/23 | 02:20pm | | American Academy of Dermatology Meeting |
03/15/23 | 04:05pm | | FY 2022 Earnings Release |
03/07/23 | 01:50pm | | Cowen Health Care Conference |
02/28/23 | | Wells Fargo West Coast Biotech Tour |
02/14/23 | 03:20pm | | SVB Securities Global Biopharma Conference |
01/12/23 | 04:00pm | | JP Morgan Healthcare Conference |
11/30/22 | 04:05pm | | Evercore ISI HealthCONx Conference |
11/16/22 | 09:00am | | Stifel Healthcare Conference |
11/15/22 | 12:20pm | | Guggenheim Immunology and Neurology Conference |
11/09/22 | 05:05pm | | Q3 2022 Earnings Release |
|
Past dividends on DICE THERAPEUTICS, INC. |
|
- No events available -
|
|
Fiscal Period : December | 2020 | 2021 | 2022 | 2023 |
Sales M $ |
Released Forecast Spread |
| 1,13 1,21 -7,2% |
|
|
Operating income (EBITDA) M $ |
Released Forecast Spread |
| -46,9 -55,9 16% | -87,4 -83,0 -5,3% | -129 |
Operating profit (EBIT) M $ |
Released Forecast Spread |
| -47,6 -58,4 19% | -88,2 -84,0 -5,0% | -129 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread |
| -49,0 -54,0 9,3% | -83,9 -82,3 -1,9% | -125 |
Net income M $ |
Released Forecast Spread | -23,7
| -49,0 -56,9 14% | -83,9 -82,7 -1,4% | -126 |
EPS $ |
Released Forecast Spread | -10,6
| -3,95 -1,93 -105% | -2,13 -2,09 -2,0% | -2,66 | Announcement Date | 07/02/2021 | 03/21/2022 | 03/15/2023 | - |
|
|
Fiscal Period : December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
Sales M $ |
Released Forecast Spread |
| 0,20 |
|
|
|
|
|
|
|
|
Operating income (EBITDA) M $ |
Released Forecast Spread | -16,0
| -16,1 -25,1 36% |
|
|
|
|
|
|
|
|
Operating profit (EBIT) M $ |
Released Forecast Spread | -16,1 -20,3 20% | -16,2 -26,4 39% |
| -21,7 -20,7 -5,0% | -21,2 -22,4 5,6% | -26,5 -22,2 -19% | -29,2 | -32,7 | -35,0 | -32,1 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread |
|
|
| -21,5 -20,5 -5,0% | -20,6 -22,3 8,0% | -23,2 -21,8 -6,5% | -27,8 | -30,3 | -32,0 | -34,2 |
Net income M $ |
Released Forecast Spread | -17,3
| -16,2 -24,1 33% | -18,6 -20,7 10% | -21,5 -20,7 -4,2% | -20,6 -22,5 8,8% | -23,2 -22,0 -5,6% | -27,8 | -30,5 | -32,3 | -34,7 |
EPS $ |
Released Forecast Spread | -0,45
| -0,44 -0,63 30% | -0,50 -0,54 7,4% | -0,58 -0,56 -4,5% | -0,55 -0,60 7,9% | -0,51 -0,48 -7,1% | -0,59 | -0,65 | -0,69 | -0,74 | Announcement Date | 11/12/2021 | 03/21/2022 | 05/12/2022 | 08/11/2022 | 11/09/2022 | 03/15/2023 | - | - | - | - | |
|
|
Upcoming sector events for DICE THERAPEUTICS, INC. |
|
|
|
Past sector events for DICE THERAPEUTICS, INC. |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|